Clinical Research Directory
Browse clinical research sites, groups, and studies.
Biophotonic Nanoparticle-enabled Laser Blood Test for Early Detection of Pancreatic Cancer
Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico
Summary
LASERBLOOD is based on a biophotonic technology that can be used to predict the development of Pancreatic Ductal Adenocarcinoma (PDAC) in particular categories of subjects at risk (e.g. persons with diabetes, obese people, patients with Intraductal Papillary Mucinous Neoplasm \[IPMN\] or other cystic diseases of the pancreas, etc.) and at the same time offer the possibility of verifying the real effectiveness of the treatments to which affected patients are subjected.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
400
Start Date
2025-09-01
Completion Date
2029-08
Last Updated
2026-06-22
Healthy Volunteers
Yes
Interventions
Diagnostic procedures
Acquisition of biological material for bio-photonic technology analysis
Locations (1)
Fondazione Policlinico Universitario Campus Bio-Medico
Rome, Italy, Italy